Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 150 participants.
Also called NCT01402843
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01402843
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01402843. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia
- Acronym
- COCTAIL
- Condition
- Hypertension
- Condition
- Dyslipidemia
- Intervention (Drug)
- pitavastatin, valsartan, placebo
- Lead sponsor
- JW Pharmaceutical
Record details
- Record id
cardio:ct-nct01402843- Content hash
b5f56592f7263a15cb8a82219725bfa14c5c8d952447f3c1610e454668c44f83